Back
CRISPR Therapeutics AG Vs. Nebius Group NV Industry Stock Comparison
Sell
48
CRSP
CRISPR Therapeutics AG
Last Price:
$54.54
Seasonality Move:
-10.93%
Buy
65
NBIS
Nebius Group NV
Last Price:
$47.08
Seasonality Move:
0.69%
Sell
48
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $51.19. The Score for CRSP is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Nebius Group NV (NBIS)
is a Buy
Is Nebius Group NV a Buy, Sell or Hold?
-
The current Nebius Group NV [NBIS] share price is $50.25. The Score for NBIS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
NBIS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $51.19Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight selling pressure.
NBIS Stock Price Chart
What is Nebius Group NV's stock price today?
-
The Nebius Group NV share price today is $50.25The current trend is moderately bearish and NBIS is experiencing slight selling pressure.
CRSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.29 | Buy |
Relative Strength Index (14 RSI): | 74.63 | Buy |
Chaikin Money Flow: | -630830 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.44 - 48.46) | Buy |
Bollinger Bands (100): | (35.81 - 45.51) | Buy |
NBIS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.27 | Buy |
Relative Strength Index (14 RSI): | 57.32 | Buy |
Chaikin Money Flow: | -1253416 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
CRSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.25 | Buy |
20-day SMA: | 45.54 | Buy |
50-day SMA: | 40.58 | Buy |
200-day SMA: | 43.25 | Buy |
8-day EMA: | 49.39 | Buy |
20-day EMA: | 46.07 | Buy |
50-day EMA: | 40.31 | Buy |
200-day EMA: | 20.99 | Buy |
NBIS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 51.23 | Sell |
20-day SMA: | 50 | Buy |
50-day SMA: | 39.23 | Buy |
200-day SMA: | 29.63 | Buy |
8-day EMA: | 50.67 | Sell |
20-day EMA: | 48.36 | Buy |
50-day EMA: | 41.83 | Buy |
200-day EMA: | 31.49 | Buy |
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.12 per share, a decrease this year of $0.23 per share, and an increase next year of $0.87 per share.
Nebius Group NV Earnings Growth & NBIS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.29 per share, and a decrease next year of $0.16 per share.
CRISPR Therapeutics AG Technical Analysis
Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nebius Group NV Technical Analysis
Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |